|
Savchenko A.A., Tikhonova E.P., Anisimova A.A., Kudryavtsev I.V., Anisimova E.N., Borisov A.G.
Relationship between NKT cell phenotype and liver fibrosis degree in patients with chronic hepatitis C before and after treatment
|
№4 / 2024
|
|
Pokrovsky V.V.
At the forefront of fight against the spread of human immunodeficiency virus
|
№2 / 2023
|
|
Minaevа S.V., Gulyaevа S.S., Kasyanova I.A., Kurakina O.Yu., Ramusheva A.D.
Regional experience in treating chronic hepatitis C in HIV-infected patients
|
№1 / 2023
|
|
Makashova V.V., Ponezheva Zh.B., Omarova Kh.G., Burkova V.N., Sergun V.P., Gorelov A.V.
Experience with populin with dihydroquercetin in novel coronavirus infection
|
№2 / 2022
|
|
Ponezheva Zh.B., Grishaeva A.A., Burdakova E.A., Makashova V.V., Astrina O.S., Usenko D.V.
Possibilities of prevention and pathogenetic therapy of a new coronavirus infection
|
№2 / 2022
|
|
Kvasov N.A., Polyakova A.K., Lopatukhin A.E., Murzakova A.V., Shemshura A.B., Kireev D.E.
Method for measurement of the size of the HIV cell reservoir and for its determination in patients who are not experienced with ART
|
№4 / 2021
|
|
Solovyev A.I., Uskov A.N., Moskalev A.V.
Malaria chemoprophylaxis during a long-term stay in an endemic area: experience with mefloquine and chloroquine
|
№2 / 2020
|
|
Ulukhanova L.U., Yaraliev M.M., Karnaeva N.S.
Anti-NMDA receptor encephalitis
|
№4 / 2019
|
|
Omarova Kh.G., Makashova V.V.
New areas in therapy for chronic hepatitis B
|
№3 / 2019
|
|
Russkikh O.E.
Latent tuberculosis infection: opportunities for diagnosis and treatment in HIV-infected patients
|
№2 / 2019
|
|
Milutina L.N., Golubev A.O., Andronova T.M.
Modern aspects of postinfectious salmonella carrying in children
|
№1 / 2019
|
|
Kochkina S.S., Sitnikova E.P.
Current approaches to treating generalized cytomegalovirus infection in infants
|
№4 / 2017
|
Русский
